FDA granted accelerated approval to umbralisib / HPBCD tablet
The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein
A forum for researchers, students and applicants in the field of cyclodextrin technology
The Food and Drug Administration granted accelerated approval to umbralisib (Ukoniq, TG Therapeutics), a kinase inhibitor including PI3K-delta and casein